Erlotinib - PDFSEARCH.IO - Document Search Engine

Erlotinib
Results: 189

#	Item
101	ORIGINAL CONTRIBUTION Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab Add to Reading List Source URL: jama.jamanetwork.com Language: English Cetuximab Panitumumab KRAS Pfizer Amines Quinazolines Gastrointestinal cancer Erlotinib Colorectal cancer Medicine Chemistry Bristol-Myers Squibb
102	NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication AFATINIB Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2014-02-03 09:11:16 Organofluorides Organochlorides Amines Alkynes Gefitinib Afatinib Erlotinib Quality of life End point of clinical trials Chemistry Organic chemistry Quinazolines
103	4 Electronic Distribution Only E BH051214 Add to Reading List Source URL: www.veristratsupport.com Language: English - Date: 2014-08-27 15:38:23 Quinazolines Amines Pfizer Alkynes Erlotinib Ethers Lung cancer Biomarker Eastern Cooperative Oncology Group Chemistry Organic chemistry Medicine
104	Consumer Health Information www.fda.gov/consumer Pancreatic Cancer: Targeted Treatments Hold Promise Add to Reading List Source URL: www.fda.gov Language: English Cancer treatments Pancreatic cancer Cancer Gemcitabine Melanoma Colorectal cancer Chemotherapy Erlotinib Lung cancer Medicine Gastrointestinal cancer Pancreas disorders
105	LETTER doi:[removed]nature11156 Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Add to Reading List Source URL: openwetware.org Language: English - Date: 2012-10-24 12:40:29 Amines Quinazolines Tyrosine kinase receptors Oncogenes Bristol-Myers Squibb Cetuximab KRAS Panitumumab Erlotinib Medicine Chemistry Biology
106	* HIGH COURT OF DELHI: NEW DELHI % Add to Reading List Source URL: lobis.nic.in Language: English - Date: 2012-09-10 08:48:04 Plaintiff Lawsuit Erlotinib Law Chemistry Organic chemistry Pfizer
107	July 2, 2010 Astellas Nominates President of OSI Pharmaceuticals, Inc. Japan, July 2, [removed]Astellas Pharma Inc. (headquarters: Tokyo; President and CEO: Masafumi Nogimori) today announced that it has nominated Naoki O Add to Reading List Source URL: www.astellas.com Language: English - Date: 2010-07-02 00:49:31 OSI Pharmaceuticals Erlotinib Pharmaceutical industry in India Chemistry Astellas Pharma Organic chemistry
108	OSI Pharmaceuticals Jenny Keeney Associate Manager, Corporate Communications Astellas US[removed] Add to Reading List Source URL: www.astellas.com Language: English - Date: 2010-12-01 19:02:48 Carcinogens Epithelial-mesenchymal transition Astellas Pharma OSI Pharmaceuticals Erlotinib Biomarker Medicine Chemistry Carcinogenesis
109	NCI’S PRECISION MEDICINE INITIATIVES FOR THE NEW NCTN National Cancer Institute’s Precision Medicine Initiatives for the New National Clinical Trials Network Jeffrey Abrams, MD, Barbara Conley, MD, Margaret Mooney, Add to Reading List Source URL: meetinglibrary.asco.org Language: English - Date: 2014-05-21 16:13:41 Lung cancer Cancer treatments Pfizer Amines Quinazolines Erlotinib Management of cancer Crizotinib Targeted therapy Medicine Oncology Chemistry
110	Microsoft PowerPoint - 1-Kucherlapati-Montreal Conference June 2010 Add to Reading List Source URL: www.cepmed.com Language: English - Date: 2010-08-24 14:18:27 Quinazolines Amines Tyrosine kinase receptors Organofluorides Lung cancer Gefitinib Erlotinib Targeted therapy KRAS Chemistry Organic chemistry Medicine

UPDATE